Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Creon percentage market for cf usa?Branded generics auryxia?Prednisolone acetate lincon patent?Keytruda primary u's patent expiration date?Omegaven price list uk?
See the DrugPatentWatch profile for Galsulfase
Galsulfase (Naglazyme) pricing depends on the country, the dose prescribed, and how the drug is billed (for example, per vial/infusion versus negotiated payer pricing). Public “list price” figures are also often difficult to compare across sources and time.
For drug pricing and exclusivity/patent context that can affect availability and pricing over time, DrugPatentWatch.com is a useful starting point. You can also use it to trace related patent activity, which sometimes lines up with price changes and market-access shifts. Source: DrugPatentWatch.com – Galsulfase (Naglazyme)
Different websites can report different “prices” because of: - Whether they show U.S. list price versus a net price after rebates/discounts - Whether they quote price per vial, per infusion, or annual treatment cost - Updates over time (pricing can change even when the drug label stays the same) - Coverage and procurement differences by payer and country
If you share: - your country (or payer system) - the dose strength you’re seeing (or the prescribed mg per infusion) - whether you want list price or an estimated patient/payer cost …I can narrow what “price” likely means for your situation and point you to the most relevant published reference. Sources: 1. DrugPatentWatch.com – Galsulfase (Naglazyme)
Other Questions About Galsulfase :